{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T21:18:18Z","timestamp":1769548698913,"version":"3.49.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:p>Indole-3-acetic acid is a common naturally occurring auxin in plants. A synthesized derivative of this compound, 4-(2,4-difluorophenyl)-2-(1H-indol-3-yl)-4-oxobutanoic acid also called mitochonic acid 5 (MA-5), has shown to increase the survival ratio of fibroblasts from patients with mitochondrial disease under stress-induced conditions. Further studies verified its efficacy in pathological models, such as an ischemia-reperfusion model, possibly by increasing ATP production. However, the efficacy of MA-5 in mental disorders, such as anxiety, schizophrenia, and autism spectrum disorders (ASD), has not been investigated. Our study focused on examining the effect of MA-5 in a mouse model of ASD induced by prenatal exposure to valproic acid (VPA). VPA exposure significantly deteriorated the level of anxiety and exploratory behavior in an open field test. We fed mice an MA-5-containing diet for 5 weeks and observed an improvement in the above behavior in the MA-5-fed groups. The efficacy of MA-5 was also observed in the elevated plus maze and three-chambered tests. These findings suggest that MA-5 could potentially be used to treat ASD, especially in patients with mitochondrial dysfunction.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000758","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T17:01:10Z","timestamp":1698944470000},"page":"488-493","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["MA-5 ameliorates autism-like behavior in mice prenatally exposed to valproic acid"],"prefix":"10.1097","volume":"34","author":[{"given":"Yasuhiro","family":"Nakagami","sequence":"first","affiliation":[{"name":"Specialty Medicine Research Laboratories II, Daiichi Sankyo Co., Ltd., Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Nishi","sequence":"additional","affiliation":[{"name":"Specialty Medicine Research Laboratories II, Daiichi Sankyo Co., Ltd., Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,10,1]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.gendis.2020.07.002","article-title":"Mitochondrial dysfunction: a hidden trigger of autism?","volume":"8","author":"Balachandar","year":"2020","journal-title":"Genes Dis"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/FBP.0000000000000316","article-title":"Suppressed play behaviour and decreased oxytocin receptor binding in the amygdala after prenatal exposure to low-dose valproic acid.","volume":"28","author":"Bertelsen","year":"2017","journal-title":"Behav Pharmacol"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000509109","article-title":"A systematic review of the valproic-acid-induced rodent model of autism.","volume":"42","author":"Chaliha","year":"2020","journal-title":"Dev Neurosci"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01837894","article-title":"Autism and lactic acidosis.","volume":"15","author":"Coleman","year":"1985","journal-title":"J Autism Dev Disord"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/jpm11030218","article-title":"Mitochondria may mediate prenatal environmental influences in autism spectrum disorder.","volume":"11","author":"Frye","year":"2021","journal-title":"J Pers Med"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"546801","DOI":"10.3389\/fpsyt.2021.546801","article-title":"The role of mitochondria in mood disorders: from physiology to pathophysiology and to treatment.","volume":"12","author":"Gim\u00e9nez-Palomo","year":"2021","journal-title":"Front Psychiatry"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1001\/jama.2010.1706","article-title":"Mitochondrial dysfunction in autism.","volume":"304","author":"Giulivi","year":"2010","journal-title":"JAMA"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.24362","article-title":"Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease.","volume":"77","author":"Gorman","year":"2015","journal-title":"Ann Neurol"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/FBP.0000000000000650","article-title":"Prenatal exposure to valproic acid and treatment with intranasal oxytocin have sex-specific effects on behavior in Long Evans rats.","volume":"32","author":"Harding","year":"2021","journal-title":"Behav Pharmacol"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1021\/cb200404c","article-title":"Rational design of an auxin antagonist of the SCF(TIR1) auxin receptor complex.","volume":"7","author":"Hayashi","year":"2012","journal-title":"ACS Chem Biol"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1096\/fj.08-128926","article-title":"Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism.","volume":"23","author":"James","year":"2009","journal-title":"FASEB J"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s11689-020-09353-y","article-title":"Controlling litter effects to enhance rigor and reproducibility with rodent models of neurodevelopmental disorders.","volume":"13","author":"Jim\u00e9nez","year":"2021","journal-title":"J Neurodev Disord"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1515\/hsz-2013-0274","article-title":"Novel intracellular functions of apolipoproteins: the ApoO protein family as constituents of the Mitofilin\/MINOS complex determines cristae morphology in mitochondria.","volume":"395","author":"Koob","year":"2014","journal-title":"Biol Chem"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"602","DOI":"10.2174\/1871527315666160413120414","article-title":"Biomarker-guided strategy for treatment of autism spectrum disorder (ASD).","volume":"15","author":"Liu","year":"2016","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1111\/bph.14435","article-title":"Sex-specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signalling.","volume":"175","author":"Melancia","year":"2009","journal-title":"Br J Pharmacol"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/0006-3223(93)90017-8","article-title":"A preliminary 31P MRS study of autism: evidence for undersynthesis and increased degradation of brain membranes.","volume":"33","author":"Minshew","year":"1993","journal-title":"Biol Psychiatry"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.cell.2009.04.024","article-title":"Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism.","volume":"137","author":"Nakatani","year":"2009","journal-title":"Cell"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","article-title":"The valproic acid-induced rodent model of autism.","volume":"299","author":"Nicolini","year":"2018","journal-title":"Exp Neurol"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/mp.2008.63","article-title":"Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate\/glutamate carrier AGC1.","volume":"15","author":"Palmieri","year":"2010","journal-title":"Mol Psychiatry"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/mp.2010.136","article-title":"Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis.","volume":"17","author":"Rossignol","year":"2012","journal-title":"Mol Psychiatry"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fphys.2014.00150","article-title":"Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism.","volume":"5","author":"Rossignol","year":"2014","journal-title":"Front Physiol"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/clinchem\/41.8.1094","article-title":"Increased urinary excretion of analogs of Krebs cycle metabolites and arabinose in two brothers with autistic features.","volume":"41","author":"Shaw","year":"1995","journal-title":"Clin Chem"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1620\/tjem.236.225","article-title":"Mitochonic acid 5 (MA-5), a derivative of the plant hormone indole-3-acetic acid, improves survival of fibroblasts from patients with mitochondrial diseases.","volume":"236","author":"Suzuki","year":"2015","journal-title":"Tohoku J Exp Med"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1681\/ASN.2015060623","article-title":"Mitochonic acid 5 binds mitochondria and ameliorates renal tubular and cardiac myocyte damage.","volume":"27","author":"Suzuki","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"111322","DOI":"10.1016\/j.biopha.2021.111322","article-title":"Emerging mechanisms of valproic acid-induced neurotoxic events in autism and its implications for pharmacological treatment.","volume":"137","author":"Taleb","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.nbd.2013.01.006","article-title":"Mitochondrial abnormalities in temporal lobe of autistic brain.","volume":"54","author":"Tang","year":"2013","journal-title":"Neurobiol Dis"},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"1125428","DOI":"10.3389\/fnins.2023.1125428","article-title":"Microglia and astrocytes underlie neuroinflammation and synaptic susceptibility in autism spectrum disorder.","volume":"17","author":"Xiong","year":"2023","journal-title":"Front Neurosci"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000758","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T22:00:29Z","timestamp":1749938429000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,1]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000758","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,1]]}}}